Literature DB >> 12100077

Endocrine consequences of premature pubarche in post-pubertal Caucasian girls.

Taly Meas1, Didier Chevenne, Elisabeth Thibaud, Juliane Léger, Sylvie Cabrol, Paul Czernichow, Claire Lévy-Marchal.   

Abstract

BACKGROUND: It has been postulated that intrauterine undernutrition may predispose to serious endocrine consequences, including precocious pubarche (PP), functional ovarian hyperandrogenism and insulin resistance syndrome.
OBJECTIVE: The aim of this study was to determine whether a history of PP was associated with the development of hyperandrogenism and/or metabolic consequences and to evaluate the effect of birth weight on this association. PATIENTS: The study population comprised 27 Caucasian girls with a history of PP and 25 healthy girls of similar age (17.4 +/- 1.3 vs. 17.7 +/- 0.9 years).
RESULTS: Gynecological age, irregular menses and oral contraceptive use were similar in the two groups. PP girls showed an increased Ferriman-Gallway Score [median (range) 8 (4-17) vs. 6 (2-10), P = 0.02] and tended to have more previous history of acne. No statistical differences were found between the groups for mean testosterone (1.7 +/- 0.7 vs. 1.4 +/- 0.7 nmol/l, P = 0.49) and dehydroepiandrosterone sulphate concentrations (7.2 +/- 3.7 vs. 5.8 +/- 2.0 micromol/l, P = 0.15), but mean Delta4-androstenedione concentrations (7.3 +/- 2.4 vs. 4.9 +/- 2.1 nmol/l, P = 0.007) and free androgen index (8.5 +/- 9.7 vs. 3.6 +/- 3.9 IU, P = 0.003) were significantly increased in the PP group. All girls showed normal glucose tolerance with an oral glucose tolerance test. Derived insulin resistance parameters were not statistically different between the two groups and fasting lipids were comparable in both groups. There was no significant effect of birth weight on androgen levels in the PP girls. Moreover, none of the PP girls demonstrated the above-described association.
CONCLUSIONS: Precocious pubarche could be the first sign of future functional ovarian hyperandrogenism but a link between this condition and intrauterine undernutrition or insulin resistance could not be demonstrated in this study.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100077     DOI: 10.1046/j.1365-2265.2002.01579.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

Review 1.  Perinatal environmental exposures affect mammary development, function, and cancer risk in adulthood.

Authors:  Suzanne E Fenton; Casey Reed; Retha R Newbold
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-10-19       Impact factor: 13.820

Review 2.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 3.  Polycystic ovary syndrome in adolescence.

Authors:  Colleen Buggs; Robert L Rosenfield
Journal:  Endocrinol Metab Clin North Am       Date:  2005-09       Impact factor: 4.741

Review 4.  Current approaches to the diagnosis and treatment of polycystic ovarian syndrome in youth.

Authors:  Katerina Harwood; Patricia Vuguin; Joan DiMartino-Nardi
Journal:  Horm Res       Date:  2007-04-05

Review 5.  The adrenal and polycystic ovary syndrome.

Authors:  Bulent O Yildiz; Ricardo Azziz
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 6.  Normal and Premature Adrenarche.

Authors:  Robert L Rosenfield
Journal:  Endocr Rev       Date:  2021-11-16       Impact factor: 19.871

7.  Higher body fat and lower fat-free mass in girls with premature adrenarche.

Authors:  Ayşe Nurcan Cebeci; Ayşegül Taş
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

8.  Reduced atherogenic indices in prepubertal girls with precocious adrenarche born appropriate for gestational age in relation to the conundrum of DHEAS.

Authors:  Ahmet Uçar; Nurçin Saka; Firdevs Baş; Nihal Hatipoğlu; Rüveyde Bundak; Feyza Darendeliler
Journal:  Endocr Connect       Date:  2012-11-19       Impact factor: 3.335

9.  Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood.

Authors:  Jani Liimatta; Pauliina Utriainen; Raimo Voutilainen; Jarmo Jääskeläinen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-10       Impact factor: 5.555

10.  Cardiometabolic Risk Profile Among Young Adult Females With a History of Premature Adrenarche.

Authors:  Jani Liimatta; Pauliina Utriainen; Tomi Laitinen; Raimo Voutilainen; Jarmo Jääskeläinen
Journal:  J Endocr Soc       Date:  2019-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.